Jason Coloma, Ph.D.

Jason Coloma, Ph.D.

Chief Executive OfficeratMaze Therapeutics· In proxies 2024–2025

Pay in FY2025-41% from the year before

Jason Coloma, Ph.D. was paid $3.5M in FY2025 (Dec), down 41%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Maze Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Maze TherapeuticsPublic company · 2 yr
    • Chief Executive Officer2024 – Present · 2 yrStock in role +99%
  2. Corporate GovernancePublic company
    • Director? – PresentNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?